Explore Rankings
Journal profile · Medicine

Regenerative Therapy

Elsevier BV · The Netherlands · ISSN 2352-3204

ITS Journal Score75.6
Global rank#3,832
Rank in Medicine#902 of 8,757
h-index49
Open access 2021–2025100%

Overview

Regenerative Therapy, published by Elsevier BV (The Netherlands), published 760 papers in 2021–2025, and its papers received 7,879 citations in those years. Its h-index is 49 and its two-year mean citedness is 5.11. On the ITS Journal Score it ranks #3,832 of 62,158 ranked journals and #902 of 8,757 in Medicine.

Key figures

Papers 2021–2025760
Citations 2021–20257,879
Citations per paper10.4
h-index49
i10-index443
2-year mean citedness5.11
Open-access share100%
Change in papers, 2020→2025+126%
Article fee (APC)US$1,800

Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.

Papers and citations by year

YearPapersCitations receivedOpen-access papers
2020982,42598
2021822,04282
20221151,656115
20231261,493126
20242161,666216
20252211,022221

What it publishes

The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.

Similar journals

Ranked journals that publish on the same topics.

JournalFieldScorePapers 2021–2025Open access
Stem Cell Research & TherapyMedicine87.12,796100%
International Journal of Stem CellsMedicine67.5191100%
Stem Cells Translational MedicineMedicine79.3672100%
Stem Cells InternationalMedicine73.2762100%
Current Stem Cell Research & TherapyMedicine66.54875%
World Journal of Stem CellsMedicine73.849796%
Stem Cell Reviews and ReportsMedicine78.794547%
Journal Of Stem Cell ResearchMedicine24.268100%

Identity and sources

  • ISSN-L: 2352-3204
  • Print ISSN: 2352-3204
  • Publisher: Elsevier BV
  • Listed in DOAJ: Yes (checked against DOAJ)
  • Crossref: Not yet checked
  • OpenAlex: S2898509233
  • Journal website: www.journals.elsevier.com

Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.

Questions

What is the ITS Journal Score of Regenerative Therapy?

It is 75.6 out of 100, which places it #3,832 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.

What is the impact factor of Regenerative Therapy?

This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 5.11.

Is Regenerative Therapy open access?

100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.

Does Regenerative Therapy charge a publication fee?

DOAJ records an article processing charge of US$1,800. Check the journal's website for the current fee and any waivers.

Transparent methodology

How the ITS Journal Score works

One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.

A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.

What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.